Related Experiment Video
Updated: Apr 11, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Rapidly progressive pneumonia caused by Cryptococcus neoformans in the patient of granulomatosis with polyangiitis
Akihiko Nakabayashi1, Masafumi Seki2, Toru Hirano1
1Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Graduate School of Medicine, Osaka University, Suita City, Osaka, Japan.
Abstract:
A 57-year-old male who had been treated for granulomatosis with polyangiitis (GPA) presented with cough and back pain that had persisted for three days. Mild infiltration shadows and nodules were found on computed tomography images at that time. Increase of GPA lesions and/or bacterial pneumonia was initially suspected. However, serum Cryptococcus neoformans antigen was positive and the chest X-ray findings had worsened by the following day despite of appropriate antibiotic treatment. Thus, pneumonia due to C. neoformans was diagnosed because C. neoformans was also isolated blood and lung tissues, and he was treated with antifungal agents: L-AMB and 5-FC, and followed up by chest radiography on a daily basis.
Insights
A patient with granulomatosis with polyangiitis developed Cryptococcus neoformans pneumonia. Early diagnosis and antifungal treatment with liposomal amphotericin B and flucytosine were crucial for management.
Area of Science:
- Infectious Diseases
- Pulmonology
- Rheumatology
Background:
- Granulomatosis with polyangiitis (GPA) is a rare autoimmune disease affecting small to medium-sized blood vessels.
- Patients with GPA, especially those on immunosuppressive therapy, are at increased risk for opportunistic infections.
- Distinguishing infectious pneumonia from GPA exacerbation can be challenging.
Purpose of the Study:
- To report a case of Cryptococcus neoformans pneumonia in a patient with a history of GPA.
- To highlight the diagnostic challenges and successful management of this rare coinfection.
- To emphasize the importance of considering opportunistic infections in immunocompromised patients presenting with respiratory symptoms.
Main Methods:
- Clinical presentation of cough and back pain in a 57-year-old male with GPA.
- Initial computed tomography (CT) revealing mild infiltration and nodules, raising suspicion for GPA exacerbation or bacterial pneumonia.
- Positive serum Cryptococcus neoformans antigen test, worsening chest X-ray findings despite antibiotics, and isolation of C. neoformans from blood and lung tissue confirmed the diagnosis.
Main Results:
- The patient presented with symptoms suggestive of respiratory infection or GPA flare.
- Despite initial antibiotic treatment for suspected bacterial pneumonia, the condition worsened.
- Diagnosis of Cryptococcus neoformans pneumonia was confirmed by positive antigen testing and fungal isolation.
- Treatment with liposomal amphotericin B (L-AMB) and flucytosine (5-FC) was initiated.
Conclusions:
- Cryptococcus neoformans pneumonia can mimic or complicate granulomatosis with polyangiitis.
- Prompt diagnostic workup, including fungal antigen testing and cultures, is essential for accurate diagnosis.
- Antifungal therapy with L-AMB and 5-FC can be effective in treating C. neoformans pneumonia in immunocompromised patients.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

